FSD Pharma Inc.: FSD Pharma Signs Agreement with Covar Pharmaceuticals to Support the Development of Lucid-PSYCH

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today

Related Keywords

Canada ,Canadian ,Zeeshan Saeed ,Lakshmip Kotra ,Anthony Durkacz ,Covar Pharmaceuticals Inc ,University Health Network ,Lucid Psycheceuticals Inc ,Fsd Pharma Inc ,Nasdaq ,Biosciences Inc ,Exchange Commission ,Pharma Inc ,Covar Pharmaceuticals ,Chief Executive Officer ,Investigational New Drug ,Controlled Substances ,Controlled Drugs ,Substances Act ,Psycheceuticals Inc ,Canadian Securities Administrators ,Pharma ,Signs ,Agreement ,Tovar ,Pharmaceuticals ,Support ,Development ,Lucid ,Psych ,